Getting Wegovy in Edinburgh: facts, not myths

The myth: 'I can just get Wegovy prescribed at my Edinburgh GP surgery'

This is the question our prescribers hear regularly from people who've read encouraging headlines. The reality is more layered. In Scotland, NHS access to semaglutide for weight management runs through specialist weight management services, consistent with NICE's appraisal of Wegovy (TA875), which recommends it only within a multidisciplinary specialist service for a maximum of two years. Scotland also applies its own clinical thresholds, which can differ from England's phased NHS rollout. Waiting lists for those specialist services in Edinburgh are real and often long. Your GP can refer you, but the path from referral to prescription is not quick.

That distinction matters for anyone researching semaglutide in Edinburgh right now. A private consultation through a regulated pharmacy sidesteps the waiting list entirely, but it does not sidestep clinical assessment, that is still required, every time. Worth checking in under a minute: visit the GPhC register and search the pharmacy's name or registration number before you hand over any details. A legitimate pharmacy will be listed there.

What the evidence actually says about Wegovy's results

The clinical trial data is the honest place to start when weighing up whether this treatment is right for you. In the STEP 1 trial, published in the New England Journal of Medicine, adults taking semaglutide 2.4mg alongside lifestyle changes lost around 15% of body weight on average over 68 weeks, a meaningful result, though individual responses genuinely vary. More recently, the MHRA approved a higher 7.2mg maintenance dose: trials at this level reported around 20.7% average weight loss over 72 weeks, narrowing the gap with tirzepatide. The titration schedule, starting at 0.25mg and progressing in roughly four-weekly steps, is set by your prescriber based on how you're tolerating treatment. No page or article should be telling you what dose you ought to be on.

Side effects are worth knowing about before you start. The most common are gastrointestinal: nausea tends to be the headline complaint, alongside loose stools, constipation, indigestion and burping. These effects are usually most pronounced when starting out or after a dose increase, and for many people they ease within a couple of weeks. Some people also notice bleeding on Wegovy, which is worth reading about so you know what to expect and when to seek advice. If you notice severe stomach pain that spreads towards your back, seek urgent medical attention, the MHRA's drug safety communications flag acute pancreatitis as a serious but infrequent risk with GLP-1 medicines. Any suspected side effects can be reported at Yellow Card.

How Edinburgh residents actually access Wegovy privately

Private access works the same way whether you live in Morningside or Manchester. You complete a clinical consultation (at nume, that is reviewed the same working day by a GPhC-registered Independent Prescriber, not software) and if you meet the criteria, treatment is dispatched the same day for free next-working-day delivery via DPD, in plain packaging. There is no separate prescription fee, no subscription, and no hidden charge for aftercare. Edinburgh's geography is irrelevant to the clinical process; what matters is your health picture.

Eligibility covers adults with a BMI of 30 or above, or from 27 upwards if you have a qualifying condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. A prescriber reviews the whole picture, not just a number on a BMI chart. If you've already been on Wegovy elsewhere and want to transfer, you'll need to provide evidence of your current dose, that is standard clinical practice, not a barrier unique to any one pharmacy. Our clinical team explains how that process works.

One thing Edinburgh searchers often overlook: the cost picture

Privately, Wegovy is priced per pen and per dose level, and the honest answer is that it is not cheap. Eli Lilly's September 2025 list-price increase for tirzepatide drew most of the headlines, but Wegovy sits in similar territory at higher doses, the weight-loss treatments overview sets out what to expect in terms of cost context, and it is worth reading before committing. What a legitimate private price always includes: the prescription itself, the clinical assessment, dispensing and delivery. If a price you see online looks dramatically lower than the market rate, that gap should prompt a question rather than a click. Counterfeit weight-loss pens are a documented problem in the UK; the MHRA has seized fake products nationally, and some contained entirely the wrong substance. Checking the GPhC register first, every time, is the single most useful habit you can build.

For anyone still weighing up whether semaglutide is the right fit, the semaglutide overview covers the mechanism, licensing and how it compares to other options. Questions about specific interactions, such as taking gabapentin alongside Wegovy, are worth raising at consultation rather than assuming from general reading. Practical questions about injection technique, including bleeding after your Wegovy shot and whether it is something to act on, are also covered in our aftercare guidance, as is advice on how Wegovy can affect your sensitivity to sunburn. When you're ready to check your eligibility, start your free consultation here.